Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 3 results found. Search for [ antiviral Virafin ]

Results 1 to 3 of 3
BusinessToday.In
April 26, 2021
As per a press release from the Hyderabad-based company, pre-clinical data has proven that Molnupiravir has broad anti-influenza activity, comprising highly potent inhibition of SARS-CoV-2 replication


BusinessToday.In
April 23, 2021
For FY21, HCL Tech's net profit rose 17.6 per cent YoY to Rs 13,011 crore, while revenue grew 6.7 per cent to Rs 75,379 crore.


BusinessToday.In
April 23, 2021
Zydus Cadila stated that 91.15 per cent of patients who were treated with the antiviral Virafin were RT-PCR negative by Day 7. The treatment also reduces hours of supplemental oxygen in patients


PAGES 1 OF 1